United States · FDA National Drug Code directory
XYOSTED
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 54436-250_c8d74eb6-fa94-446a-8307-091436a536dc
- Product NDC
- 54436-250
- Form
- INJECTION
- Composition / generic term
- testosterone enanthate
- Labeler
- Antares Pharma, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20181115
- Source listing expiry
- 20271231
Source-listed ingredients
- TESTOSTERONE ENANTHATE — 50 mg/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE in 1 CARTON (54436-250-01) / .5 mL in 1 SYRINGE (54436-250-03) · 54436-250-01
- 4 SYRINGE in 1 CARTON (54436-250-04) / .5 mL in 1 SYRINGE (54436-250-02) · 54436-250-04
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →